# How to Taper Off GLP-1: A Step-by-Step Protocol Source: https://www.dietglp.com/blog/tapering-off-glp1/ Published: 2026-04-11 Keywords: taper off ozempic, stop wegovy slowly, glp-1 taper schedule, mounjaro tapering off **TL;DR:** Taper GLP-1 over 4–6 months by stepping down dose every 8–12 weeks. Maintain protein and lifting throughout. Stretch dose intervals (every 2 weeks → every 3 weeks) before stopping fully. Watch weight weekly; restart at low maintenance dose if regain begins. If you've decided to stop your GLP-1 medication, the question is not just whether to stop, but how. The rebound rates in trials are calculated from patients who stopped abruptly. A deliberate taper produces meaningfully better outcomes for most patients. ## Why taper instead of cold turkey Three reasons: 1. **Appetite returns gradually.** A taper allows you to practice managing each level of returning hunger before it gets stronger. 2. **Habits consolidate.** Each step gives you weeks at a new level to confirm your protein, lifting, and routine hold. 3. **You can detect early drift.** A rebound on a step-down is a signal to hold or restart, not a full year of regain. ## The general taper protocol Talk to your prescriber for your specific situation, but the typical approach: **Phase 1 (months 1–2 off-ramp):** Step down to the next-lower dose level. Maintain for 8–12 weeks. Confirm: - Weight is stable or still slowly decreasing - Protein intake hasn't dropped - Lifting routine hasn't slipped - You can hit your eating windows without distress **Phase 2 (months 3–4):** Step down to the next dose. Same 8–12 weeks. Same checks. Hunger is more present now; this is the stretch where most habit slippage happens. **Phase 3 (months 5–6):** Either step down to the lowest dose available, OR maintain the prior step but stretch the dosing interval (e.g., every 10 days instead of weekly). **Phase 4 (months 7+):** If you've been stable through Phase 3, consider: - Stopping entirely - Maintaining at the lowest dose long-term - Maintaining at extended intervals (every 2 weeks) ## Specific drug examples ### Semaglutide (Ozempic, Wegovy) Standard down-step pattern: - 2.4 mg → 1.7 mg (8–12 weeks) - 1.7 mg → 1.0 mg (8–12 weeks) - 1.0 mg → 0.5 mg (8–12 weeks) - 0.5 mg → 0.25 mg (8 weeks) - 0.25 mg → stop, OR every 2 weeks at 0.25 mg, OR maintain ### Tirzepatide (Mounjaro, Zepbound) - 15 mg → 12.5 mg (8 weeks) - 12.5 mg → 10 mg (8 weeks) - 10 mg → 7.5 mg (8–12 weeks) - 7.5 mg → 5 mg (8–12 weeks) - 5 mg → 2.5 mg (8 weeks) - 2.5 mg → stop, OR every 2 weeks, OR maintain ### Liraglutide (Saxenda) - 3.0 mg → 2.4 mg (4 weeks) - 2.4 mg → 1.8 mg (4 weeks) - 1.8 mg → 1.2 mg (4 weeks) - 1.2 mg → stop (Liraglutide is daily and shorter-acting, so the taper can be quicker, but the principle is the same.) ## What to monitor during the taper **Weekly weigh-in.** Same day, same time, same conditions. Track the trend, not the daily noise. **Weekly protein audit.** Are you still hitting your floor? If not, add a shake. **Weekly training log.** Sessions completed? Weights moving up? **Sleep quality.** Some patients sleep better as GLP-1 dose decreases (less GI discomfort); some sleep worse (more food noise at night). Track. **Appetite patterns.** Where is hunger showing up that wasn't there before? Plan for it. **Mood and energy.** Some patients experience low-mood symptoms in the first weeks of each step-down. Usually resolves. ## What to do if regain starts during taper A 2–4 lb gain over a step-down is normal and not a stop signal — water and glycogen redistribute as appetite normalizes. A 5+ lb gain over a single step, or a clear 1+ lb/week trend, is signal: **Option A:** Hold at the current dose for an additional 8–12 weeks. Reinforce habits. See if weight stabilizes. **Option B:** Step back up to the previous dose. Stay there for 8–12 weeks. Try the step-down again. **Option C:** Accept that you may be a long-term maintenance patient. Many are. There is no failure here. The medication is doing what it does. The decision tree is about practical management. ## What to do after fully stopping **Months 1–2 off:** Hunger ramps. Habits matter. Daily structure matters. **Months 3–6 off:** This is when most rebound shows up. Weekly weigh-ins. Honest food audits if drift starts. **Months 6–12 off:** New equilibrium. If you're stable here, you have a real shot at long-term maintenance. **Year 2+:** The further you go, the better the prognosis — but rebound can still happen if habits collapse. ## Restart criteria If you stopped fully and want to restart, the medical conversation usually looks at: - Sustained 5%+ regain over months - Active deterioration of metabolic markers - Loss of function or quality of life - Strong patient preference Restarting at a low maintenance dose is increasingly common and considered medically reasonable. The framing of GLP-1 as a chronic-disease medication (like blood pressure meds) supports this. ## Long-term maintenance dose For patients who decide to stay on indefinitely: - **Semaglutide 0.25–0.5 mg/week** is enough for many to maintain - **Tirzepatide 2.5–5 mg/week** is enough for many - **Every-other-week dosing** is an option some prescribers use - The cost is real but lower than the higher doses - The side effects are usually minimal at maintenance doses This is a personal medical decision. There is no universal right answer. ## Bottom line Tapering off GLP-1 over 4–6 months meaningfully outperforms cold-turkey stopping for most patients. Step down every 8–12 weeks, monitor weight and habits, hold or restart if regain begins. Many patients should consider staying on a low maintenance dose long-term rather than stopping fully — the data supports treating these as chronic medications rather than temporary tools.